‘Software is not a medical device': FDA medtech chief battles for control of mHealth

Pitts to Shuren: 'Software is not a medical device'

The conversation got a bit heated this week as the House Energy & Commerce Committee’s subcommittee on Health sparred with FDA medical device chief Jeffrey Shuren over regulation of mobile medical and healthcare applications.

Shuren maintained that medical applications should fall under FDA purview regardless of their role in a primarily medical platform or on a mobile device, especially since more medical device makers are developing adjuncts to smartphones and tablets rather than building new technologies from scratch.

"Manufacturers don’t have to make the hardware anymore," Shuren told the subcommittee, chaired by Rep. Joe Pitts (R-Penn.). "That’s the way the world is changing."

The FDA in September released its final rule regarding medical applications for mobile platforms, largely taking a hands-off approach and focusing its oversight on a small subset of applications that it deemed risky enough to harm patients if not working as intended. That means the majority of healthcare apps won’t be regulated under the FDA’s charter, but those strokes were still too broad for some members of Congress who have put their support behind the SOFTWARE Act, seeking to further limit the FDA’s oversight of mobile healthcare technologies.

Challengers include participants in this weeks’ subcommittee meeting, some of them allies of Rep. Marsha Blackburn’s (R-Tenn.) SOFTWARE Act, which would restrict the FDA’s authority only to software that turns a mobile device into a medical device or software that complements medical technology. Blackburn’s SOFTWARE Act would keep the FDA out of mobile apps that the bill calls "clinical" or "health" software.

Shuren argued that new technologies that perform health and medical functions that have previously fallen under the FDA’s purview should get the same treatment as their predecessors, regardless of the platform, MobiHealthNews reported.

"The impact and the risk to patients is the same," he said. "Simply because they got smaller and I can pick it up and walk out of the room with it, doesn’t change the risk to the patients. Why for that reason alone would we treat it differently?"

Shuren got some support in the panel, namely from Rep. Henry Waxman (D-Calif.) who agreed that the rise of healthcare applications on consumer smartphones and tablets have complicated the issue of proper FDA regulation, but Rep. Pitts took a much more black-and-white approach to the problem.

"Software is not a medical device," he said in opening remarks for the panel discussion. "To regulate it as such, the FDA has said it will use discretion to decide which software to regulate. Except that no matter what Dr. Shuren may tell this committee here today, there is no guarantee that his successor won’t go back on this guidance tomorrow."

The FDA’s final mHealth rules feature some amount of flexibility in the agency’s authority to decide which applications merit extra attention, leaving developers with significant uncertainty in developing new products.

"While guidance is a valuable tool for the FDA, there is a significant limitation – certainty," Pitts said. "What stands today could change tomorrow."

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]


  1. says

    I just want to tell you that I am all new to weblog and really enjoyed you’re web-site. Almost certainly I’m going to bookmark your blog . You really come with impressive article content. With thanks for revealing your web page.


  1. Nice article

    Apakah kamu membutuhkan obat herbal de Nature Indonesia silahkan dapat hubungi customer service kita secara langsung melalui SMS ataupun Telepon. Kami selalu online 24 jam utk melayani pembelian obat herbal de Nature.

Leave a Reply